Search results
Results From The WOW.Com Content Network
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. [2] Founded in 1990, the company has twenty-three employees.
Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). [1] There is some evidence it may improve some ME/CFS symptoms. [1] It is an immunomodulatory double-stranded RNA drug similar to the prototypical RNA poly I:C.
The biotechnology sector is growing in the New York City area, based upon the region's strength in academic scientific research and public and commercial financial support. By mid-2014, Accelerator, a biotech investment firm, had raised more than US$30 million from investors, including Eli Lilly and Company, Pfizer, and Johnson & Johnson, for ...
Shares of thinly-traded microcap AIM ImmunoTech Inc. (NYSE: AIM ) are trading sharply higher after the company announced the Department of Defense granted a four-year, $6.42 million "Breakthrough ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Mail. Call live aol support at. 1-800-358-4860. Get live expert help with your AOL needs—from email and passwords, technical questions, mobile email and more.
Apoptosis inhibitor of macrophage. Apoptosis inhibitor of macrophage (AIM) is a protein produced by macrophages that regulates immune responses and inflammation. It plays a crucial role in key intracellular processes like lipid metabolism and apoptosis.
Sign in to your AOL account to access your email and manage your account information.